News

Madrigal Pharmaceuticals Announces Grants of Inducement Awards under Nasdaq Listing Rule 5635(c)(4)

Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL), a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), today announced that it ...

The FDA Just Approved a New Use for Wegovy, and Novo Nordisk Stock is Climbing. Here's What Investors Need to Know

On Friday, Novo Nordisk announced that the U.S. Food and Drug Administration (FDA) had approved Wegovy for the treatment of ...
Pharmabiz18h

Madrigal Pharma’s Rezdiffra gets European Commission’s conditional marketing nod to treat MASH with moderate to advanced liver fibrosis

Conshohocken, Pennsylvania Thursday, August 21, 2025, 14:00 Hrs [IST] ...